Barnstaple
North Devon town; Accord Healthcare site supplying 9% of NHS prescriptions by volume.
Last refreshed: 22 April 2026
Why does a north Devon market town supply nearly one in ten NHS prescriptions?
Timeline for Barnstaple
Mentioned in: LSIMF sends £80m+ to four regional sites
UK Startups and Innovation- How much did Accord Healthcare in Barnstaple receive from the LSIMF?
- Accord Healthcare's Barnstaple site received over £45m from the Life Sciences Innovative Manufacturing Fund in April 2026, one of the largest single awards in the 2026 round.Source: DSIT LSIMF announcement
- What share of NHS prescriptions come from Barnstaple?
- Accord Healthcare's Barnstaple manufacturing site produces 9% of all NHS prescriptions by volume, making it one of the most significant pharmaceutical sites in the UK.Source: DSIT LSIMF announcement
- What is the Life Sciences Innovative Manufacturing Fund?
- The LSIMF is a UK Government fund that awards capital grants to life-sciences manufacturers. In April 2026 it allocated over £80m to four regional sites, deliberately outside the Oxford-Cambridge-London triangle.Source: DSIT
Background
Barnstaple entered the national life-sciences map on 14 April 2026, when the Life Sciences Innovative Manufacturing Fund (LSIMF) awarded Accord Healthcare over £45m to expand its manufacturing site in the town. Accord's Barnstaple facility already produces 9% of all NHS prescriptions by volume, making it one of the most consequential pharmaceutical manufacturing sites in the UK outside the Golden Triangle. The LSIMF investment is among the largest single awards in the programme's 2026 round.
Barnstaple is the principal town of north Devon, situated on the River Taw approximately 40 miles north of Exeter. It serves as the commercial and administrative centre for the surrounding rural area, with a population of around 25,000. The town is the main railhead for north Devon and hosts North Devon District Hospital. Its economy has historically been tied to agriculture, retail, and public services, with Accord Healthcare representing its most significant industrial employer.
The LSIMF award reflects a deliberate Treasury policy to steer life-sciences capex beyond the Oxford-Cambridge-London corridor. Barnstaple's selection demonstrates that high-volume pharmaceutical manufacturing can anchor major state investment outside traditional research clusters, provided the operational track record is already there. For the town, the award represents a substantial anchor for skilled manufacturing employment in a region where such opportunities are rare.